LBF20207PG44: Difference between revisions
No edit summary |
No edit summary |
||
Line 7: | Line 7: | ||
|LipidMaps=LMFA03010113 | |LipidMaps=LMFA03010113 | ||
|SysName=(1,9alpha,11alpha,15S) -Tetrahydroxyprosta- (5-cis,13-trans) -dien | |SysName=(1,9alpha,11alpha,15S) -Tetrahydroxyprosta- (5-cis,13-trans) -dien | ||
|Common Name=&&Prostaglandin | |Common Name=&&Prostaglandin F_2 alpha alcohol&&(1,9alpha,11alpha,15S) -Tetrahydroxyprosta- (5Z,13E) -dien&& | ||
|Source= | |Source= | ||
|Chemical Synthesis= | |Chemical Synthesis= |
Revision as of 10:10, 3 June 2010
LipidBank Top (トップ) |
Fatty acid (脂肪酸) |
Glycerolipid (グリセロ脂質) |
Sphingolipid (スフィンゴ脂質) |
Journals (雑誌一覧) |
How to edit (ページの書き方) |
IDs and Links | |
---|---|
LipidBank | XPR1783 |
LipidMaps | LMFA03010113 |
CAS | |
KEGG | {{{KEGG}}} |
KNApSAcK | {{{KNApSAcK}}} |
mol | LBF20207PG44 |
Prostaglandin F2α alcohol | |
---|---|
Structural Information | |
(1,9α,11α,15S) -Tetrahydroxyprosta- (5-cis,13-trans) -dien | |
| |
Formula | C20H36O4 |
Exact Mass | 340.26135963999997 |
Average Mass | 340.49744 |
SMILES | C(CC[C@H](O)C=C[C@H]([C@H]1CC=CCCCCO)[C@@H](C[C@@H]1O)O)CC |
Physicochemical Information | |
PGF2 alpha Alcohol is reported to retain ocular hypotensive properties , but the target receptor is not cleared yet. Woodward_DF et al. | |
Spectral Information | |
Mass Spectra | |
UV Spectra | |
IR Spectra | |
NMR Spectra | |
Other Spectra | |
Chromatograms |
Reported Metabolites, References | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
|